Literature DB >> 182718

Male pseudohermaphroditism presumably due to target organ unresponsiveness to androgens. Deficient 5alpha-dihydrotestosterone binding in cultured skin fibroblasts.

M Kaufman, C Straisfeld, L Pinsky.   

Abstract

Maximum specific 5alpha-dihydrotestosterone (DHT) binding activity (Bmax) had been measured in intact confluent monolayers representing fibroblast strains derived form nongenital and genital (labium majus) skin of normal individuals and of 11 patients fulfilling the clinicogenetic criteria of complete testicular feminization (TF). Nine labium majus strains from adult females had a mean Bmax value three times greater than that of seven nongenital strains from adult females (33 vs. 11 fmol/mg cell protein). The Bmax results for 13 adult nongenital strains varied from 5.6 to 23.3 fmol/mg protein; the values for males and females had very similar means and ranges. The variation could not be correlated with the chronologic age of adult skin explant donors or with the in vitro age (mean population doubling level) of the cultures assayed. The Bmax activities of three nongenital strains from normal infants (two male, one female) did not exceed 5 fmol/mg protein. Seven of eight nongenital TF strains had Bmax values below 2 fmol/mg protein; the value for the eighth coincided with the lower limit of normal adults. The lower limit of DHT binding in normal labium majus strains was 15 fmol/mg protein. Three of five labial strains from patients with TF had Bmax values close to zero; the other two fell between 10 and 15 fmol/mg protein. It is apparant that labial skin fibroblast strains from clinically homogeneous patients with TF had highly variable degrees of DHT binding deficiency, and that they permit a more reliable diagnosis of severe and intermediate degrees of DHT binding deficiency than do strains of nongenital skin fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182718      PMCID: PMC333189          DOI: 10.1172/JCI108478

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  FURTHER OBSERVATIONS ON THE SYNDROME, "TESTICULAR FEMINIZATION".

Authors:  J M MORRIS; V B MAHESH
Journal:  Am J Obstet Gynecol       Date:  1963-11-15       Impact factor: 8.661

2.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

3.  Qualitative differences in testosterone metabolism as an indication of cellular heterogeneity in fibroblast monolayers derived from human preputial skin.

Authors:  M Kaufman; L Pinsky; C Straisfeld; B Shanfield; B Zilahi
Journal:  Exp Cell Res       Date:  1975-11       Impact factor: 3.905

4.  Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.

Authors:  G Schneider; M Genel; A M Bongiovanni; A S Goldman; R L Rosenfield
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

5.  Locus on human X chromosome for dihydrotestosterone receptor and androgen insensitivity.

Authors:  W J Meyer; B R Migeon; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

6.  Androgen receptor in human skin fibroblasts. Characterization of a specific 17beta-hydroxy-5alpha-androstan-3-one-protein complex in cell sonicates and nuclei.

Authors:  B S Keenan; W J Meyer; A J Hadjian; C J Migeon
Journal:  Steroids       Date:  1975-04       Impact factor: 2.668

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Diminished 5alpha-reductase activity in extracts of fibroblasts cultured from patients with familial incomplete male pseudohermaphroditism, type 2.

Authors:  R J Moore; J E Griffin; J D Wilson
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

9.  Letter: Skin biopsy site and biology of fibroblast strains.

Authors:  M Kaufman; L Pinsky
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

10.  Androgen insensitivity in man: evidence for genetic heterogeneity.

Authors:  J A Amrhein; W J Meyer; H W Jones; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

View more
  12 in total

1.  Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.

Authors:  L Prior; S Bordet; M A Trifiro; A Mhatre; M Kaufman; L Pinsky; K Wrogeman; D D Belsham; F Pereira; C Greenberg
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

2.  An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity.

Authors:  T J Sai; S Seino; C S Chang; M Trifiro; L Pinsky; A Mhatre; M Kaufman; B Lambert; J Trapman; A O Brinkmann
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

Review 3.  Management of disorders of sex development.

Authors:  Olaf Hiort; Wiebke Birnbaum; Louise Marshall; Lutz Wünsch; Ralf Werner; Tatjana Schröder; Ulla Döhnert; Paul-Martin Holterhus
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

4.  Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.

Authors:  L K Beitel; P Kazemi-Esfarjani; M Kaufman; R Lumbroso; A M DiGeorge; D W Killinger; M A Trifiro; L Pinsky
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

5.  Male pseudohermaphroditism: diagnosis in cell culture.

Authors:  L Pinsky; M Kaufman; B Lambert; G Faucher; R Rosenfeld
Journal:  Can Med Assoc J       Date:  1977-06-04       Impact factor: 8.262

6.  Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome.

Authors:  T R Brown; D B Lubahn; E M Wilson; D R Joseph; F S French; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  DHT-receptor in cultured human fibroblasts: binding study in a family with androgen insensitivity (complete testicular feminisation).

Authors:  E Donti; I Nicoletti; P Filipponi; G Venti; V Bocchini; F Santeusanio
Journal:  J Med Genet       Date:  1982-10       Impact factor: 6.318

8.  The presence of androgen-binding receptors in genital and nongenital skin fibroblasts.

Authors:  J Herfert; T F Wienker; H H Ropers
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

9.  Carrier detection in the testicular feminisation syndrome: deficient 5 alpha-dihydrotestosterone binding in cultured skin fibroblasts from the mothers of patients with complete androgen insensitivity.

Authors:  M B Hodgins; E M Duke; D Ring
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

Review 10.  Cultured human skin fibroblasts: a model for the study of androgen action.

Authors:  T R Brown; C J Migeon
Journal:  Mol Cell Biochem       Date:  1981-04-13       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.